AgRP neurons are required for the weight-lowering effects of GLP-1 receptor agonists in female mice
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2614476123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Mateus d'Ávila und 8 weiteren Autor:innen. Beteiligte Einrichtung: Interdepartmental Neuroscience Program, Department of Neuroscience, Yale Graduate School of Arts and Sciences, Yale University, New Haven, CT 06510. Hauptthemen laut MEDLINE: Agouti-Related Protein, Neurons, Glucagon-Like Peptide-1 Receptor Agonists, Weight Loss. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), HHS | NIH | National Institute of General Medical Sciences (NIGMS).
Abstract (Originalsprache)
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), including semaglutide, produce robust and sustained weight loss, yet the central mechanisms supporting their long-term efficacy remain incompletely understood. Agouti-related peptide (AgRP) neurons of the arcuate nucleus are classically activated by negative energy balance and promote feeding and energy conservation. Based on this framework, GLP-1RAs have generally been expected to suppress or bypass AgRP neuron activity. Here, we report that AgRP neuron activation is required for the full weight-lowering effects of GLP-1RAs in female mice. Across complementary AgRP loss-of-function models, disruption of AgRP circuit integrity reduced the full weight-lowering effects of GLP-1RAs. This requirement varies with sex, diet, and mode of AgRP disruption. We found that GLP-1RA treatment is associated with increased markers of neuronal activation, mitochondrial engagement, and synaptic remodeling in AgRP neurons. We further identify a glucocorticoid-to-AgRP signaling axis as an important pathway mediating this functional recruitment of AgRP neurons. Together, these findings reveal that contrary to prevailing assumptions, GLP-1RA engages AgRP neurons to sustain weight loss, highlighting an unexpected role for these neurons in coordinating adaptive metabolic responses to pharmacologically induced negative energy balance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Interdepartmental Neuroscience Program, Department of Neuroscience, Yale Graduate School of Arts and Sciences, Yale University, New Haven, CT 06510.
- Department of Comparative Medicine, Yale School of Medicine, Yale University, New Haven, CT 06510.
- Division of Integrative Physiology, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, United Kingdom.
- Department of Pharmacology, Yale School of Medicine, New Haven, CT 06510.
ORCID-Profile: Joseph Schlessinger, Giuseppe D'Agostino
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
Zitieren
APA
d'Ávila, M., Cavalcanti-de-Albuquerque, J., Collado-Pérez, R., Liu, Z. W., Hunter, J., White, A., Schlessinger, J., D'Agostino, G., & Horvath, T. L. (2026). AgRP neurons are required for the weight-lowering effects of GLP-1 receptor agonists in female mice. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2614476123
Vancouver
d'Ávila M, Cavalcanti-de-Albuquerque J, Collado-Pérez R, Liu ZW, Hunter J, White A, et al. AgRP neurons are required for the weight-lowering effects of GLP-1 receptor agonists in female mice. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2614476123
BibTeX
@article{dvila2026,
author = {d'Ávila, Mateus and Cavalcanti-de-Albuquerque, João and Collado-Pérez, Roberto and Liu, Zhong-Wu and Hunter, Jenna and White, Anne and Schlessinger, Joseph and D'Agostino, Giuseppe and Horvath, Tamas L},
title = {AgRP neurons are required for the weight-lowering effects of GLP-1 receptor agonists in female mice},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2614476123}
}
EUVIMED